Accuray | ARAY - SCHULD





SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
Accuray USD 170.24M 4.52M 2024-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 73.38M 3.35M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Edwards Lifesciences USD 600M 105.4M 2026-03
Inogen USD 0 0 2022-06
Mesa Laboratories USD 204.98M 7.27M 2024-09
Orthofix International USD 137.23M 338K 2024-09
Surmodics USD 29.55M 111K 2024-09
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Trinity Biotech USD 100.76M 7.05M 2024-12